NCT07133750View on ClinicalTrials.gov

PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2029

Conditions

CRC (Colorectal Cancer)

Interventions

DRUG

PM8002

IV infusion

DRUG

Chemotherapy Regimen 1

IV infusion

DRUG

Chemotherapy Regimen 2

Oral administration and IV infusion

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

BioNTech SE

INDUSTRY

lead

Biotheus Inc.

INDUSTRY